New publication alert 🚨
We are proud to see the latest work of Jens Frisvad and our colleagues Jan Lehmbeck, Javier Sáez Sáez, Birgitte Andersen and José Arnau published in Current Opinion in Biotechnology.
Precision fermentation promises to reshape the world’s food supply, but reaching cost parity with animal production requires unprecedented protein titers.
Our exclusive license to one of the most advanced A. oryzae expression platforms in the world, developed at Novonesis, provides a powerful starting point to obtain commercially viable titers, for BLG and the many other proteins and peptides we help bring to market.
‘Evolution at the speed of fermentation’ discusses our strain engineering approach and the strategies our teams implement to further optimize yields and unlock price competitiveness with animal dairy proteins.
And they deliver: our beta-lactoglobulin program is already reaching cost parity with animal-derived BLG. What’s next?
